Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy

Published:2021-08 Issue: Volume:170 Page:105751
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Giovarelli Matteo,Zecchini Silvia,Catarinella Giorgia^ORCID,Moscheni Claudia,Sartori Patrizia^ORCID,Barbieri Cecilia^ORCID,Roux-Biejat Paulina,Napoli Alessandra^ORCID,Vantaggiato Chiara^ORCID,Cervia Davide,Perrotta Cristiana,Clementi Emilio,Latella Lucia,De Palma Clara^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference80 articles.

1. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis;Crisafulli;Orphanet J. Rare Dis.,2020

2. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies;Wallaceand;Annu Rev. Physiol.,2009

3. Pharmacological advances for treatment in Duchenne muscular dystrophy;Guiraudand;Curr. Opin. Pharmacol.,2017

4. Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers;Shkryl;Pflug. Arch.,2009

5. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy;Millay;Nat. Med.,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary mitochondrial dysfunction across the spectrum of hereditary and acquired muscle disorders;Mitochondrion;2024-09

2. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response;Cells;2024-07-09

3. Systemic Treatment of Body‐Wide Duchenne Muscular Dystrophy Symptoms;Clinical Pharmacology & Therapeutics;2024-07-04

4. Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia;Ageing Research Reviews;2024-04

5. Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy;Cells;2024-03-26